Explore 3 Stock Ideas & Industry Insights Download Free Report

small-cap

One NYSE-Listed Tobacco Stock at Resistance Levels – Universal Corporation

Jun 02, 2025 | Team Kalkine
One NYSE-Listed Tobacco Stock at Resistance Levels – Universal Corporation
Image source: shutterstock

  • UVV:NYSE
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (US$)

Company Overview: Universal Corporation (NYSE: UVV) is a global business-to-business agriproducts company. The Company is a global leaf tobacco supplier and provides plant-based ingredients to food and beverage end markets. The Company operates through two segments: Tobacco Operations and Ingredients Operations. The Tobacco Operations segment activities involve contracting, procuring, processing, packing, storing, and shipping leaf tobacco for sale to, or for the account of, manufacturers of consumer tobacco products throughout the world. 

 As per our previous Kalkine’s Diversified Opportunities Report published on ‘UVV’ on 08th May 2025, Kalkine provided a ‘Buy’ stance on the stock at USD 58.47, based on Universal Corporation's (UVV) recent financial and operational achievements, including preliminary Q3 2025 sales and operating revenues of USD 937.2 million, an operating income of USD 100.7 million, strong demand driving a 91.2% revenue contribution from its Tobacco Operations segment, an efficient operating margin of 11.6% in Tobacco Operations, and advancements in its Ingredients Operations with a focus on high-demand value-added products, giving a return of 11.83%, attaining resistance 1 and resistance 2.

Current Macro and company specific rationales:

  • Impact of Trade Tensions on Tobacco Exports: The ongoing U.S.-China trade conflict, with China imposing a 30% tariff on U.S. imports, significantly affects Universal Corporation (UVV), a global leader in tobacco and agricultural products, by increasing export costs for its tobacco shipments, potentially disrupting market access in key regions like Asia, which could lead to reduced revenues and margin compression for its core tobacco segment.
  • S. Recession Concerns Influencing Demand: With U.S. recession fears noted in economic discussions around May 2025, UVV faces risks of declining demand for tobacco products as consumer spending tightens and retailers reduce inventory amid economic uncertainty, potentially impacting the company’s sales volumes and overall revenue growth in its primary markets.
  • Regulatory Pressures on Tobacco Industry: UVV operates in a heavily regulated tobacco industry, facing risks from evolving global regulations, such as potential new restrictions on tobacco sales and marketing in the EU and other regions, which could impose compliance costs or fines, straining operational efficiency and profitability as the company navigates these legislative challenges.
  • Volatility in Agricultural Commodity Prices: UVV’s exposure to agricultural commodity markets subjects it to price volatility in tobacco and other crops, driven by factors like weather conditions, global supply chain disruptions, and fluctuating demand, which could increase sourcing costs, pressure margins, and create financial uncertainty if market conditions remain unstable in 2025.

Noted below are the details of support and resistance levels provided in our previous report:

Relative Valuation (Price/Earnings based relative valuation):

UVV’s Daily Chart 

Considering the current trading levels, volatile macro environment, lower intrinsic value as per P/E relative valuation, tariffs uncertainties, resistance 1 and resistance 2 attainment, and risks associated, aSell’ rating is assigned to the “UVV” at the closing market price of USD 65.39, as of May 30, 2025. 

Note: This report may be updated with details around fundamental and technical analysis, price/ chart in due course, as appropriate

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is May 30, 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.’ 


Disclaimer-

Disclaimer This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.

Past performance is not a reliable indicator of future performance.